Literature DB >> 32532909

Biochemistry may be misleading in metachronous MEN2A-associated phaeochromocytoma following unilateral total adrenalectomy.

Anthony-Joe Nassour1,2, Carolina Nylen3, Mark Sywak4, Roderick Clifton-Bligh5.   

Abstract

A 63-year-old woman with multiple endocrine neoplasia type 2A (MEN2A) presented with recurrent spells of headaches, sweats and palpitations decades after right adrenalectomy for phaeochromocytoma, and total thyroidectomy for medullary thyroid cancer. She was hypertensive and in sinus rhythm. DOTA-TATE positron-emission tomography (PET) demonstrated a 12mm enhancing left adrenal incidentaloma. 24 hours urine catecholamines, and multiple plasma metanephrine and normetanephrine measurements were all within normal reference ranges. Based on her symptoms and imaging findings, left adrenalectomy was performed and found a 40 mm phaeochromocytoma. Her symptoms have since completely resolved and plasma metanephrine is now undetectable MEN2-associated phaeochromocytomas are often bilateral and may be metachronous. Patients at high risk of phaeochromocytoma who develop symptoms of catecholamine excess should be carefully evaluated even if plasma or urinary metanephrines are within the normal reference range. Biochemical reference ranges for metanephrines need to be adjusted accordingly in patients who have had prior unilateral total adrenalectomy. © BMJ Publishing Group Limited 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  adrenal disorders; endocrine cancer; endocrinology; general surgery; surgical diagnostic tests

Mesh:

Substances:

Year:  2020        PMID: 32532909      PMCID: PMC7295374          DOI: 10.1136/bcr-2019-234132

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  18 in total

1.  Differences between sporadic and multiple endocrine neoplasia type 2A phaeochromocytoma.

Authors:  F J Pomares; R Cañas; J M Rodriguez; A M Hernandez; P Parrilla; F J Tebar
Journal:  Clin Endocrinol (Oxf)       Date:  1998-02       Impact factor: 3.478

2.  Role of RET genetic variants in MEN2-associated pheochromocytoma.

Authors:  Débora Rodrigues Siqueira; Lucieli Ceolin; Carla Vaz Ferreira; Mírian Romitti; Silvana Cavalcante Maia; Léa Maria Zanini Maciel; Ana Luiza Maia
Journal:  Eur J Endocrinol       Date:  2014-03-10       Impact factor: 6.664

3.  High penetrance of pheochromocytoma in multiple endocrine neoplasia 2 caused by germ line RET codon 634 mutation in Japanese patients.

Authors:  Tsuneo Imai; Shinya Uchino; Takahiro Okamoto; Shinichi Suzuki; Shinji Kosugi; Toyone Kikumori; Akihiro Sakurai
Journal:  Eur J Endocrinol       Date:  2013-04-15       Impact factor: 6.664

Review 4.  Laboratory evaluation of pheochromocytoma and paraganglioma.

Authors:  Graeme Eisenhofer; Mirko Peitzsch
Journal:  Clin Chem       Date:  2014-10-20       Impact factor: 8.327

5.  Pheochromocytomas, multiple endocrine neoplasia type 2, and von Hippel-Lindau disease.

Authors:  H P Neumann; D P Berger; G Sigmund; U Blum; D Schmidt; R J Parmer; B Volk; G Kirste
Journal:  N Engl J Med       Date:  1993-11-18       Impact factor: 91.245

6.  Limitations of intraoperative adrenal remnant volume measurement in patients undergoing subtotal adrenalectomy.

Authors:  Michael Brauckhoff; Karsten Stock; Susanne Stock; Kerstin Lorenz; Carsten Sekulla; Katrin Brauckhoff; Phuong Nguyen Thanh; Oliver Gimm; Rolf Peter Spielmann; Henning Dralle
Journal:  World J Surg       Date:  2008-05       Impact factor: 3.352

7.  Unilateral and bilateral adrenalectomy for pheochromocytoma requires adjustment of urinary and plasma metanephrine reference ranges.

Authors:  Thamara E Osinga; Maartje H A van den Eijnden; Ido P Kema; Michiel N Kerstens; Robin P F Dullaart; Wilhelmina H A de Jong; Wim J Sluiter; Thera P Links; Anouk N A van der Horst-Schrivers
Journal:  J Clin Endocrinol Metab       Date:  2013-01-30       Impact factor: 5.958

8.  The characterization of pheochromocytoma and its impact on overall survival in multiple endocrine neoplasia type 2.

Authors:  Sonali Thosani; Montserrat Ayala-Ramirez; Lynn Palmer; Mimi I Hu; Thereasa Rich; Robert F Gagel; Gilbert Cote; Steven G Waguespack; Mouhammed Amir Habra; Camilo Jimenez
Journal:  J Clin Endocrinol Metab       Date:  2013-09-12       Impact factor: 5.958

Review 9.  [Function-preserving adrenalectomy for adrenal tumors].

Authors:  M Brauckhoff; H Dralle
Journal:  Chirurg       Date:  2012-06       Impact factor: 0.955

10.  A systematic review of the literature examining the diagnostic efficacy of measurement of fractionated plasma free metanephrines in the biochemical diagnosis of pheochromocytoma.

Authors:  Anna M Sawka; Ally PH Prebtani; Lehana Thabane; Amiram Gafni; Mitchell Levine; William F Young
Journal:  BMC Endocr Disord       Date:  2004-06-29       Impact factor: 2.763

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.